ClinicalTrials.gg
Not yet recruitingNCT07942675CALI-PEDUpdated Nov 17, 2026

Indirect Calorimetry-Guided Nutritional Support in Mechanically Ventilated Children (CALI-PED)

An interventional study of Indirect Calorimetry-Guided Nutritional Support in Critical Illness and Nutritional Support, sponsored by University Hospital, Montpellier. Not yet recruiting at 1 site in France. Open to participants aged 0 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Supportive care

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
0 Years to 17 Years
Sex
All
01

Study summary

Adequate nutritional support is essential in critically ill children receiving invasive mechanical ventilation. Current nutritional prescriptions are commonly based on predictive equations, which may inaccurately estimate individual energy requirements and contribute to underfeeding or overfeeding.

CALI-PED is a single-center, prospective, interventional pilot study designed to evaluate whether indirect calorimetry-guided nutritional support reduces interindividual variability in energy intake adequacy among mechanically ventilated children in the pediatric intensive care unit (PICU).

Fifty children will be prospectively enrolled and compared with a historical cohort of 141 patients managed using conventional nutritional targets based on the Schofield predictive equation. In the prospective cohort, resting energy expenditure will be measured daily using indirect calorimetry, for up to seven days of invasive mechanical ventilation, and enteral caloric prescriptions will be adjusted accordingly.

The primary outcome is the interindividual variability in the ratio of actual energy intake to the reference energy target on days 2 and 3 of mechanical ventilation. Secondary outcomes include protein intake, agreement between predicted and measured energy requirements, changes in resting energy expenditure over time, duration of mechanical ventilation, PICU length of stay, and incidence of nosocomial infections.

This pilot study aims to determine whether indirect calorimetry can improve the individualization and consistency of nutritional support in critically ill children.

Read the detailed description

**Background and Rationale** Nutritional support is a key component of pediatric intensive care. Inadequate nutritional intake has been associated with prolonged mechanical ventilation, increased nosocomial infections, longer intensive care and hospital stays, and higher mortality.

Current international guidelines recommend early nutritional assessment and suggest indirect calorimetry as the preferred method for determining resting energy expenditure (REE). However, nutritional prescriptions in routine clinical practice frequently rely on predictive equations, particularly the Schofield equation, which may not accurately reflect the metabolic requirements of critically ill children.

A previous retrospective study conducted in our PICU, involving 141 mechanically ventilated children, demonstrated persistent variability in energy intake on days 2 and 3 despite the implementation of a standardized enteral nutrition protocol. These findings suggest that individualizing energy targets using directly measured REE could improve nutritional adequacy.

**Study Design and Population** CALI-PED is a single-center, prospective, non-randomized, interventional pilot study conducted at Montpellier University Hospital, France.

The prospective cohort will include 50 children younger than 18 years, weighing at least 10 kg, receiving invasive mechanical ventilation through a cuffed endotracheal tube, with an expected ventilation duration exceeding 48 hours.

The prospective cohort will be compared with a previously collected historical cohort of 141 mechanically ventilated children managed using conventional nutritional targets based on the Schofield predictive equation.

**Intervention** In the prospective cohort, REE will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit.

Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Before each measurement, respiratory settings must have remained unchanged for at least one hour. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period.

Daily enteral energy prescriptions will be adjusted according to the measured REE, expressed in kcal/day and kcal/kg/day.

**Primary Outcome** The primary outcome is the interindividual dispersion of the ratio between actual energy intake and the reference energy target on days 2 and 3 of mechanical ventilation.

The reference energy target will be defined as:

  • Measured REE obtained by indirect calorimetry in the prospective cohort.
  • Estimated energy requirements calculated using the Schofield equation in the historical cohort.

Interindividual dispersion will be assessed using the interquartile range and coefficient of variation.

**Secondary Outcomes**

Secondary outcomes include:

  • Comparison of protein intake (g/kg/day) between cohorts on days 2 and 3.
  • Comparison of Schofield-predicted energy requirements with indirect calorimetry-measured REE in the prospective cohort.
  • Description of daily changes in measured REE during invasive mechanical ventilation, up to day 7.
  • Exploratory comparison of mechanical ventilation duration, PICU length of stay, and incidence of nosocomial infections between cohorts.

Nosocomial infections will be defined as infections occurring at least 48 hours after admission, according to Centers for Disease Control and Prevention criteria.

**Statistical Analysis** The distributions of energy intake adequacy ratios will be compared between the prospective and historical cohorts using appropriate statistical methods. Normality will be assessed using the Shapiro-Wilk test, and continuous variables will be compared using parametric or non-parametric tests as appropriate.

Additional analyses may account for differences between the prospective and historical cohorts, including propensity score methods.

Clinical outcomes will be considered exploratory, as the study is not powered to demonstrate differences in clinical endpoints.

**Study Duration and Ethical Considerations** The recruitment period is expected to last 30 months. Participants will be followed until PICU discharge or day 28 after inclusion, whichever occurs first.

The study was approved by the Comité de Protection des Personnes Île-de-France VII on August 5, 2026 (reference 26.02032.000560). Written informed consent will be obtained from at least one parent or legal guardian, and assent will be obtained from the child whenever feasible.

02

Conditions studied

  • Critical Illness
  • Nutritional Support

Browse trials for

Keywords

  • Indirect Calorimetry
  • Pediatric Intensive Care
  • Mechanical Ventilation
  • Enteral Nutrition
  • Resting Energy Expenditure
03

In context

Critical Illness

1,785 studies on the registry are indexed under Critical Illness; 444 are open to participants now.

This study's planned enrollment of 50 is below the median of 90 across 929 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,262 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children younger than 18 years of age.
  • Body weight ≥10 kg.
  • Invasive mechanical ventilation.
  • Expected duration of invasive mechanical ventilation >48 hours.
  • Child's assent to participate, whenever feasible.
  • Written obtained from at least one parent or legal guardian.

Exclusion criteria

Exclusion Criteria:

  • Limitation or withdrawal of life-sustaining treatment planned at the time of admission to the pediatric intensive care unit.
  • Brain death.
  • Requirement for a specific dietary regimen due to an underlying condition, including diabetic ketoacidosis or an inherited metabolic disorder.
  • Gastrointestinal disorders interfering with enteral nutrition, including short bowel syndrome or malabsorption.
  • Participation in another research study with an ongoing exclusion period.
  • Concurrent participation in another interventional clinical trial that could interfere with the present study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Indirect Calorimetry-Guided Nutrition

    Fifty mechanically ventilated children will receive individualized enteral nutritional support guided by daily indirect calorimetry measurements. Resting energy expenditure will be measured from day 2 until extubation, for a maximum of seven days, and enteral caloric prescriptions will be adjusted accordingly.

    Procedure: Indirect Calorimetry-Guided Nutritional Support

Interventions

  • ProcedureIndirect Calorimetry-Guided Nutritional Support

    Resting energy expenditure (REE) will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit. Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period. Daily enteral caloric prescriptions will be adjusted according to the measured REE.

06

What researchers measure

Primary outcomes

  1. Interindividual Variability in Energy Intake Adequacy on Days 2 and 3 of Mechanical Ventilation

    Interindividual variability in the ratio of actual energy intake (kcal/kg/day) to the reference energy target will be compared between the prospective and historical cohorts on days 2 and 3 of mechanical ventilation. The reference energy target is defined as resting energy expenditure measured by indirect calorimetry in the prospective cohort and energy requirements estimated using the Schofield equation in the historical cohort. Interindividual variability will be primarily quantified using the interquartile range (IQR) of the energy intake adequacy ratio. The coefficient of variation (CV) will be calculated as a complementary measure of dispersion.

    Time frame: Days 2 and 3 of invasive mechanical ventilation

Secondary outcomes

  1. Daily Protein Intake on Days 2 of Mechanical Ventilation

    Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 2 of invasive mechanical ventilation.

    Time frame: Days 2 of invasive mechanical ventilation

  2. Daily Protein Intake on Days 3 of Mechanical Ventilation

    Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 3 of invasive mechanical ventilation.

    Time frame: Days 3 of invasive mechanical ventilation

  3. Difference Between Predicted and Measured Resting Energy Expenditure

    Difference between energy requirements estimated using the Schofield predictive equation and resting energy expenditure measured by indirect calorimetry in the prospective cohort, expressed in kcal/day.

    Time frame: Days 2 to 7 of invasive mechanical ventilation

  4. Daily Changes in Measured Resting Energy Expenditure

    Daily resting energy expenditure measured by indirect calorimetry, expressed in kcal/day, will be described from day 2 until extubation, for a maximum of seven days of invasive mechanical ventilation, in the prospective cohort.

    Time frame: Days 2 to 7 of invasive mechanical ventilation

  5. Duration of Invasive Mechanical Ventilation

    Duration of invasive mechanical ventilation, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome.

    Time frame: From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment

  6. Pediatric Intensive Care Unit Length of Stay

    Length of stay in the pediatric intensive care unit, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome.

    Time frame: From PICU admission until PICU discharge, assessed up to day 28 after enrollment

  7. Incidence of Nosocomial Infections

    Proportion of patients developing at least one nosocomial infection, defined as an infection occurring at least 48 hours after PICU admission according to Centers for Disease Control and Prevention criteria. This exploratory clinical outcome will be compared between the prospective and historical cohorts.

    Time frame: From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first

07

Study locations

1 site
08

References and documents

Publications

  • Ceci C, Baleine J, Huguet H, Cambonie G, Picot MC, Morice C, Polito A, Gaudaire A, Milesi C, Gavotto A. Nutritional goals in mechanically ventilated children: Impact of a standardized enteral protocol in a tertiary pediatric intensive care unit. Clin Nutr ESPEN. 2026 Jun;73:102985. doi: 10.1016/j.clnesp.2026.102985. Epub 2026 Feb 26. PubMed 41763487 ↗

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available due to the sensitive nature of clinical information collected from critically ill pediatric patients and applicable data protection requirements. Study results will be disseminated through scientific publications and presentations in aggregated form.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jun 2029, 29 months later.

Of 403 non-industry interventional studies with no phase under Critical Illness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 29 months is above that.

Counting every sponsor, half of 407 studies reached it within 21 months; a quarter within 11 and three quarters within 40.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 17, 2026
StartEst.
Jan 2027
Primary completionEst.
Jun 2029
CompletionEst.
Jul 2029
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942675
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jun 2029 (estimated)
Completion
Jul 2029 (estimated)
Last update
Nov 17, 2026

Study contacts

Arthur Gavotto, MD, PhD
Contact
a-gavotto@chu-montpellier.fr
+33 4 67 33 66 09
Arthur Gavotto
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion